James Fingleton

2.4k total citations
74 papers, 972 citations indexed

About

James Fingleton is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, James Fingleton has authored 74 papers receiving a total of 972 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Pulmonary and Respiratory Medicine, 39 papers in Physiology and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in James Fingleton's work include Asthma and respiratory diseases (37 papers), Respiratory and Cough-Related Research (25 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers). James Fingleton is often cited by papers focused on Asthma and respiratory diseases (37 papers), Respiratory and Cough-Related Research (25 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers). James Fingleton collaborates with scholars based in New Zealand, United States and Australia. James Fingleton's co-authors include Richard Beasley, Mark Weatherall, Irene Braithwaite, Mark Holliday, Philip G. Bardin, Sarah A. Hiles, Vanessa Clark, Guy B. Marks, Vanessa M. McDonald and Peter Wark and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Scientific Reports.

In The Last Decade

James Fingleton

70 papers receiving 963 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James Fingleton New Zealand 17 610 534 114 92 56 74 972
T W van der Mark Netherlands 17 1.2k 2.0× 796 1.5× 54 0.5× 127 1.4× 58 1.0× 40 1.6k
Britton United Kingdom 12 378 0.6× 629 1.2× 37 0.3× 88 1.0× 176 3.1× 18 1.2k
Füsun Yıldız Türkiye 14 389 0.6× 361 0.7× 14 0.1× 128 1.4× 48 0.9× 69 735
Filippo Catalano Italy 20 1.0k 1.7× 690 1.3× 46 0.4× 311 3.4× 39 0.7× 55 1.5k
Gabriele Nicolini Italy 24 1.7k 2.7× 1.6k 3.0× 35 0.3× 59 0.6× 120 2.1× 55 2.0k
Cristina Bárbara Portugal 17 535 0.9× 337 0.6× 104 0.9× 71 0.8× 26 0.5× 105 1.1k
Christopher Burgess United Kingdom 9 391 0.6× 503 0.9× 41 0.4× 131 1.4× 46 0.8× 30 939
Dennis Bowie Canada 14 663 1.1× 617 1.2× 60 0.5× 42 0.5× 88 1.6× 25 1.0k
Fernando De Benedetto Italy 15 883 1.4× 704 1.3× 25 0.2× 60 0.7× 50 0.9× 48 1.2k
Luís J. Nannini Argentina 19 1.0k 1.7× 855 1.6× 44 0.4× 38 0.4× 20 0.4× 47 1.3k

Countries citing papers authored by James Fingleton

Since Specialization
Citations

This map shows the geographic impact of James Fingleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Fingleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Fingleton more than expected).

Fields of papers citing papers by James Fingleton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Fingleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Fingleton. The network helps show where James Fingleton may publish in the future.

Co-authorship network of co-authors of James Fingleton

This figure shows the co-authorship network connecting the top 25 collaborators of James Fingleton. A scholar is included among the top collaborators of James Fingleton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Fingleton. James Fingleton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fingleton, James, Jenny Sparks, Richard Beasley, et al.. (2025). Treatable Trait Guided Asthma Management: A Feasibility Study. Respirology. 30(6). 480–492. 2 indexed citations
2.
Levack, William, Mark Weatherall, Harry McNaughton, et al.. (2023). Taking Charge After Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Randomized Controlled Feasibility Trial of a Psychologically Informed Self-Management Intervention. International Journal of COPD. Volume 18. 317–325. 4 indexed citations
3.
Yap, Elaine, et al.. (2022). A survey of adult respiratory and sleep services in Aotearoa New Zealand: inequities in the provision of adult respiratory and sleep services. New Zealand Medical Journal. 135(1566). 49–68. 2 indexed citations
4.
Braithwaite, Irene, James Harper, Ingrid Maijers, et al.. (2021). Rhinothermy delivered by nasal high flow therapy in the treatment of the common cold: a randomised controlled trial. BMJ Open. 11(11). e047760–e047760.
5.
Baggott, Christina, Jo Hardy, Jenny Sparks, et al.. (2021). Epinephrine (adrenaline) compared to selective beta-2-agonist in adults or children with acute asthma: a systematic review and meta-analysis. Thorax. 77(6). 563–572. 9 indexed citations
6.
Hatter, Lee, Pepa Bruce, Irene Braithwaite, et al.. (2020). ICS-formoterol relieverversusICS and short-acting β2-agonist reliever in asthma: a systematic review and meta-analysis. ERJ Open Research. 7(1). 701–2020. 45 indexed citations
7.
Baggott, Christina, Paul Hansen, Robert J. Hancox, et al.. (2020). What matters most to patients when choosing treatment for mild–moderate asthma? Results from a discrete choice experiment. Thorax. 75(10). 842–848. 14 indexed citations
8.
Baggott, Christina, Amy Hai Yan Chan, Sally Hurford, et al.. (2020). Patient preferences for asthma management: a qualitative study. BMJ Open. 10(8). e037491–e037491. 20 indexed citations
9.
Baggott, Christina, Jo Hardy, Jenny Sparks, et al.. (2020). Self-titration of inhaled corticosteroid and β2-agonist in response to symptoms in mild asthma: a pre-specified analysis from the PRACTICAL randomised controlled trial. European Respiratory Journal. 56(4). 2000170–2000170. 7 indexed citations
10.
McDonald, Vanessa M., James Fingleton, Àlvar Agustí, et al.. (2019). Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report. European Respiratory Journal. 53(5). 1802058–1802058. 199 indexed citations
11.
Bardsley, George, Janine Pilcher, Steven McKinstry, et al.. (2018). Oxygen versus air-driven nebulisers for exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial. BMC Pulmonary Medicine. 18(1). 157–157. 20 indexed citations
12.
Conway, Aaron, et al.. (2018). Accuracy and precision of transcutaneous carbon dioxide monitoring: a systematic review and meta-analysis. Thorax. 74(2). 157–163. 49 indexed citations
13.
Bardsley, George, Peter T. Daley‐Yates, Amanda Baines, et al.. (2018). Anti-inflammatory duration of action of fluticasone furoate/vilanterol trifenatate in asthma: a cross-over randomised controlled trial. Respiratory Research. 19(1). 133–133. 14 indexed citations
14.
Ebmeier, Stefan, Alex Semprini, Rachel Varughese, et al.. (2018). Change in biomarkers of type-2 inflammation following severe exacerbations of asthma. Thorax. 74(1). 95–98. 16 indexed citations
15.
Fingleton, James, Jo Hardy, Christina Baggott, et al.. (2017). Description of the protocol for the PRACTICAL study: a randomised controlled trial of the efficacy and safety of ICS/LABA reliever therapy in asthma. BMJ Open Respiratory Research. 4(1). e000217–e000217. 13 indexed citations
16.
McKinstry, Steven, Janine Pilcher, George Bardsley, et al.. (2017). Nasal high flow therapy and PtCO2 in stable COPD: A randomized controlled cross‐over trial. Respirology. 23(4). 378–384. 28 indexed citations
17.
Fingleton, James, Kewu Huang, Mark Weatherall, et al.. (2017). Phenotypes of symptomatic airways disease in China and New Zealand. European Respiratory Journal. 50(6). 1700957–1700957. 7 indexed citations
18.
Fingleton, James, Justin Travers, Mathew Williams, et al.. (2015). Treatment responsiveness of phenotypes of symptomatic airways obstruction in adults. Journal of Allergy and Clinical Immunology. 136(3). 601–609. 34 indexed citations
19.
Kocks, Janwillem, Mark Weatherall, Esther Metting, et al.. (2014). Phenotyping airways disease by cluster analysis in primary care: 6 distinct clusters identified. European Respiratory Journal. 44(Suppl 58). 1977–1977. 1 indexed citations
20.
Fingleton, James, et al.. (2013). Efficacy of Micromobile Foot Compression Device in Increasing Lower Limb Venous Blood Flow. International Journal of Vascular Medicine. 2013. 1–6. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T W van der Mark Breakdown of academic impact, for papers by Britton Breakdown of academic impact, for papers by Füsun Yıldız Breakdown of academic impact, for papers by Filippo Catalano Breakdown of academic impact, for papers by Gabriele Nicolini Breakdown of academic impact, for papers by Cristina Bárbara Breakdown of academic impact, for papers by Christopher Burgess Breakdown of academic impact, for papers by Dennis Bowie Breakdown of academic impact, for papers by Fernando De Benedetto Breakdown of academic impact, for papers by Luís J. Nannini
Rankless by CCL
2026